Overview
To document the clinical outcome of Rezūm therapy for BPH patient in Canadian cohort.
Eligibility
Inclusion Criteria:
- Male subjects of ≥ 18 years of age.
- Primary diagnosis of Benign Prostate Hypertrophy (BPH).
- Candidate for Rezūm therapy as per clinical decision of Investigator.
- Willing and able to accurately complete the required questionnaires.
- Willing and able to provide signed and dated informed consent
Exclusion Criteria:
- Characteristics indicating a poor compliance with study protocol requirements.
- Disease or other health condition that is not suitable for this study.
- Unable or unwilling to provide signed informed consent.